Preterm birth is the #1 cause of newborn death in Ohio
The aim of the OPQC Progesterone Project is to reduce the rate of premature births in Ohio at <37 weeks by 10% and births at <32 weeks by 10% by July 1, 2016 by increasing the screening, identification, and treatment of pregnant women at risk for preterm birth who will benefit from progesterone.
Progesterone is an evidence-based therapy shown to reduce preterm birth by more than 30% in women with prior preterm birth and/or short cervix through identification and treatment of appropriate candidates with progesterone prophylaxis.
OPQC is currently testing strategies for implementing this intervention with 23 Obstetrics outpatient clinics that were identified by OPQC’s 20 Charter OB sites. Successful strategies will then be disseminated to the other OB practices in Ohio.